The suspense of the IV GMP Conference has been revealed
The full formal program of the event was published on the official website of the IV All-Russian GMP-conference with international participation. The role of the pharmaceutical industry in the national economy, the export potential of pharmaceutical companies in different regions, the EAEU single market, medicines marking, health-care expenditures, pharmacopoeia standards, manufacture of radiopharmaceuticals and blood products, as well as specific considerations of all GxP standards will be discussed by regulators, manufacturers and distributors from Latin America to South-East Asia on September 23-25 in Kaliningrad region.
Today, the organizers of the IV All-Russian GMP-conference have published the structure of the conference program that will be held under the motto «Good Practices: bringing industry and world together». This year, the Ministry of Industry and Trade of the Russian Federation together with the State Institute of Drugs and Good Practices (SID&GP) have suggested the regulators and representatives of pharmaceutical companies devoting a plenary session to the importance and role of the pharmaceutical industry in the economic development of countries.
“Indeed, today the pharmaceutical sector is one of the most successfully developing sectors of industry around the world: breakthrough discoveries are taking place there to ensure a decent life for our citizens and prevent their diseases. At the same time, we take into account that the issues of medicines availability, accessibility and quality, continue to be the topic number one, even in countries with rigid regulatory systems. That is why we invited our colleagues from Latin America, Japan, India, Europe, the USA, Africa and the EAEU to take part in the conference”, – commented Vladislav Shestakov, Director of SID&GP, on the choice of key topics and considerable representation of foreign GMP-inspectorates at the event.
Even at the stage of program formulation of the main autumn event for the pharmaceutical market, the trend for export development of medicines and medical devices manufacturers became obvious. In addition, this trend is typical not only for Russia, where export is one of the key target indicators in the upcoming “FHARMA – 2030” strategy.
Traditionally, the organizers of the GMP Conference expect great interest to the master class conducted by the Russian State GMP-inspectorate. By the way, this year it will be held on September 24 and 25.
Moreover, the topical issue of the 2019 pharmaceutical season – medicines marking, will not neglected as well, where the representatives of the Federal Service for Surveillance in Healthcare of the Russian Federation, the Russian Development Center of Advanced Technologies, industry associations and pilot project participants will evaluate the status of system’s readiness and its participants before the final lap.
“GMP Conference is one of the important tools of the pharmaceutical industry self-organization, a platform where professionals from all over the world discuss the most relevant issues, share experiences, look for and find mutually beneficial approaches to solving the most difficult problems”, – noted Grigory Potapov, Chief Executive Officer, Pharmstandard JSC. In addition, judging by the IV All-Russian GMP Conference program, it is also a universal platform, where each participant will find an interesting and relevant topic related to his experience.
The program of the IV All-Russian GMP Conference is available on the following website link: http://gosgmp.ru/programma-konferentsii/.
Dates and venue of the event: September 23-25, 2019, Svetlogorsk city (Kaliningrad region), «Yantar-hall» (Lenin str., 11)
ATTENTION! You can register for the Conference until September 13. Have a chance to choose the preferable conditions for participation on the website of the event.
The general partner of the conference is Pharmstandard JSC, strategic partners are JSC Roche-Moscow and the Moscow office of the Hungarian company Gedeon Richter. Official partners are AMGEN LLC, Russian company Pharmasyntez and Takeda Pharmaceuticals LLC.
The partners of the Conference are JSC Astellas Pharma, JSC Sanofi, R-Pharm Group of Companies. Regional partners – Miramistin and Ecobaltic Industrial Park, special partner – Bosnalijek pharmaceutical company. The partners of certain sessions will be PRO.MED.CS Praha a.s., JSC Akrihin and JSC Obolenskoe, Alium Group of Companies, GEROPHARM LLC.
The organizers of the IV All-Russia GMP-Conference are the Ministry of Industry and Trade of the Russian Federation together with the State Institute of Drugs and Good Practices (SID & GP), the Conference’s operator is corporate communication center “S-GROUP”.
- Russia will be able to join PIC/S and break into new pharmaceutical markets
- Mutual trust is the fundamental principle of building relationships between the EAEU member countries
- «SID & GP» specialists held the advanced training course at the premises of SPbSRIVS
- Director of the SID & GP dispels myths about Russian medicines
- Try on the role of the GMP-inspector